Green Education – Christmas Special: Innovations From Another Field


Personal Note From Patrick, The Editor

Hi Reader, today we’re talking about biomaterials.

As a little Christmas special, I'd like to take you on a small journey today.

Because what is currently tested in the medical field can teach us a lot about what more sustainable materials might look like.

First, however, I want to give a big shout-out to Nourhan Hassan, who inspired this piece and worked on it with me.

Now, let’s see what innovations could await us in the near future:


Today's Lesson: Innovations In Materials

About biomaterials and their sustainability


Number Of The Day

In 2024, the WHO estimated that 16 billion injections are administered globally each year. While it is estimated that 90% of medical device waste consists of single-use items (leading to more than 5 million tons of medical waste produced every year in the U.S. alone) only 15% is believed to be biohazardous. As a result, several more sustainable innovations are trying to enter the market.

90


Biomaterials And Their Sustainability

Biomaterials might represent a long-awaited solution for drug delivery and surgical treatment - both for humans and even our lab rodents.

They entail a wide range of substances engineered to interact safely with living tissue.

> This means that the “bio” refers to their interaction, not their origin.

Therefore, titanium also qualifies as a biomaterial - lightweight, corrosion-resistant, and capable of fusing well with bone, making it ideal for orthopedic and dental implants.

In other words, biomaterials can range from metals to plastics and from natural materials to synthetic ones.

This also explains why biomaterials are used in everything from tissue scaffolds and joint replacements to drug delivery systems.

Now consider that the medical plastics market alone was valued at $46.11 billion in 2021, with a projected annual growth rate of 7.5% through 2030.

That means there is a lot of potential and much need for more sustainable alternatives…

The Green Side of Biomaterials

The biomaterials of interest for us come mostly from biological sources and therefore offer better biodegradability.

An exciting example is collagen. It can be derived from bovine hide or fish waste.

Since collagen is the most common protein in the human body, it can be safely absorbed without requiring surgical removal.

This, in turn, means lower environmental impacts due to avoided follow-up procedures.

Another interesting material in this class is chitosan.

As Mawazi et al. and Ul-Islam and colleagues discuss, it is derived from crustacean shells and has antimicrobial properties.

These properties therefore make it valuable for wound dressings and drug delivery systems.

However, we also meet our old friend polylactic acid (PLA), often made from biological sources and with improved degradability.

While its use in medicine is developing, we already see lab items such as plates made from it.

However, while these advantages are interesting for how we deliver drugs or design lab items, we need to look at the bigger picture.

When "Bio" Doesn’t Mean "Green"

While PLA is generally made from sugarcane or cornstarch - often leading to overall carbon footprint reductions - its production still requires significant land and water use.

Moreover, the fermentation and polymerization processes involved in PLA production are far from clean.

When we move to materials like titanium, we can learn another important lesson.

We want to highlight its biocompatibility and durability, but titanium ore extraction and manufacturing are extremely energy-intensive - far more so than steel.

Still, companies such as PTSMAKE reportedly recycle almost all of the titanium they use.

That means, even though titanium wouldn't readily come to mind as a more sustainable alternative, under the right circumstances it can be.

Finally, collagen can be extracted from waste streams like fish skin, which sounds ideal.

However, producing medical-grade collagen requires energy-intensive purification, chemical processing, and sterilization.

Just because materials have a biological origin, doesn’t mean they are green when we consider their processing.

Another challenge is that use cases strongly influence end-of-life treatment.

While materials with insufficient performance are not sustainable, considering other steps only after development also prevents real progress.

Adoption of greener materials is hampered because, although often biodegradable, after use, they are regularly classified as infectious or hazardous.

And even when not, according to the WHO, globally only 61% of hospitals have basic healthcare waste management systems, and in low-resource settings this number drops to just 25%.

Thus, even a biodegradable wound dressing will likely end up in high-temperature incineration once removed.

The lesson learned: sustainability depends on our technical capabilities.

Applying The Knowledge

Looking to the future of biomaterials - and, by extension, more sustainable lab items - we can identify five major challenges:

  • Higher Upfront Costs
    Solution: Given their longer lifetimes, fewer follow-up treatments like removals or cheaper end-of-life treatments, money can be saved long term.
  • Concerns About Quality
    Solution: Realizing that generally innovations have been tested and once they enter the market there is normally enough data to know where to use them.

  • Actual Footprints
    Solution: Here it truly needs our diligence to determine under which conditions a solution is truly more sustainable.

  • Lack Of Infrastructure
    Solution: Indeed, we might have to start separating waste or work with 3rd parties to establish appropriate end-of-life treatment.
  • Missing Procurement Inclusion
    Solution: Implementing sustainability as the other decision criterion to quality/performance

Nevertheless, innovations are on their way.

Now it’s on us to learn from the lessons already made and include these materials in our research and purchasing decisions.


How We Feel Today


References

Mahdi, M., et al., 2024. Classification of biomaterials and their applications. Journal of Port Science Research, 7(3), pp.281–299. doi:10.36371/port.2024.3.7281.

Meison Furtado, L., et al., 2022. Development of fish collagen in tissue regeneration and drug delivery. Engineered Regeneration, 3(3), pp.217–231. doi:10.1016/j.engreg.2022.05.002.

Ul-Islam, M., et al., 2024. Chitosan-based nanostructured biomaterials: Synthesis, properties, and biomedical applications. Advanced Industrial and Engineering Polymer Research, 7(1), pp.79–99. doi:10.1016/j.aiepr.2023.07.002.

Mawazi, S.M., et al., 2024. Recent applications of chitosan and its derivatives in antibacterial, anticancer, wound healing, and tissue engineering fields. Polymers, 16, 1351. doi:10.3390/polym16101351.

Yang, Z., et al., 2024. Medical applications and prospects of polylactic acid materials. iScience, 27(12), 111512. doi:10.1016/j.isci.2024.111512.

Khouri, N.G., et al., 2024. Polylactic acid (PLA): Properties, synthesis, and biomedical applications – A review of the literature. Journal of Molecular Structure, 1309, 138243. doi:10.1016/j.molstruc.2024.138243.

Islam, M.M., et al., 2025. Environmental footprint of polylactic acid production utilizing cane-sugar and microalgal biomass: An LCA case study. Journal of Cleaner Production, 496, 145132. doi:10.1016/j.jclepro.2025.145132.

Tebaldo, V., et al., 2024. Sustainable recovery of titanium alloy: From waste to feedstock for additive manufacturing. Sustainability, 16, 330. doi:10.3390/su16010330.

Nematollahi, H., et al., 2025. Medical waste management in the modern healthcare era: A comprehensive review of technologies, environmental impact, and sustainable practices. Results in Engineering, 28, 107210. doi:10.1016/j.rineng.2025.107210.

Demir, E., et al., 2011. A comparative analysis of several vehicle emission models for road freight transportation. Transportation Research Part D: Transport and Environment, 16(5), pp.347–357. doi:10.1016/j.trd.2011.01.011.

Shih, L.-H., et al., 2003. Multicriteria optimization for infectious medical waste collection system planning. Practice Periodical of Hazardous, Toxic, and Radioactive Waste Management, 7(2), pp.78–87. doi:10.1061/(ASCE)1090-025X(2003)7:2(78).


If you have a wish or a question, feel free to reply to this Email.

Otherwise, wish you a beautiful week!
See you again on the 1st : )

Find the previous lesson click - here -


Edited by Patrick Penndorf
Connection@ReAdvance.com
Lutherstraße 159, 07743, Jena, Thuringia, Germany
Data Protection & Impressum

If you think we do a bad job: Unsubscribe

ReAdvance

Here to share how we can make labs greener - based on my personal experience and those from labs all around the world

Read more from ReAdvance

Personal Note From Patrick, The Editor Hello Reader, how do we identify sustainable practices? As you might know, I work as an advisor for universities, institutes, and companies. Lately, I came across a prime examples of how we can drive change using three simple tactics. Let’s discover what these are and how you can copy-paste them: Today's Lesson: Tactics To Find And Implement How we can identify and safely drive change in labs Number Of The Day More than 50 years ago - in 1971 to be...

Personal Note From Patrick, The Editor Hi Reader, preparation or action? Obviously, one cannot succeed without the other. But talking about preparation is often underappreciated because most people want action as fast as possible. Yet this impatience can lead them to achieve less in the end: Today's Lesson: How To Prepare For Change What we can do to pave the way for sustainability Number Of The Day Sometimes we have to be patient. Waiting for the right moment is hard, but often worth it....

Personal Note From Patrick, The Editor Hi Reader, have you ever changed a running system? It’s not a good idea. I've never done it in research, but I’ve unfortunately done it outside of it. However, changing the system at the right time is one of the best ideas - and this subtle difference is important. Let’s find out how to drive change safely and why it’s more a question of tactics than science: Today's Lesson: How To Drive Change Safely Tactics and insights on how to make processes greener...